JP4933455B2 - 新規のインスリン誘導体 - Google Patents

Info

Publication number

JP4933455B2

JP4933455B2 JP2007553601A JP2007553601A JP4933455B2 JP 4933455 B2 JP4933455 B2 JP 4933455B2 JP 2007553601 A JP2007553601 A JP 2007553601A JP 2007553601 A JP2007553601 A JP 2007553601A JP 4933455 B2 JP4933455 B2 JP 4933455B2

Authority

JP

Japan

Prior art keywords

tert

insulin

mmol

acid

added

Prior art date

2005-02-02

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired - Fee Related

Links

• Espacenet
• Global Dossier
• Discuss

• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical class N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title claims description 280
• PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 claims description 100
• 101000976075 Homo sapiens Insulin Proteins 0.000 claims description 96
• 102000004877 Insulin Human genes 0.000 claims description 91
• 108090001061 Insulin Proteins 0.000 claims description 91
• 229940125396 insulin Drugs 0.000 claims description 91
• -1 carboxyethyl Chemical group 0.000 claims description 78
• 239000004026 insulin derivative Substances 0.000 claims description 54
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 51
• 229910052757 nitrogen Inorganic materials 0.000 claims description 27
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 23
• VEVRNHHLCPGNDU-MUGJNUQGSA-O desmosine Chemical compound OC(=O)[C@@H](N)CCCC[N+]1=CC(CC[C@H](N)C(O)=O)=C(CCC[C@H](N)C(O)=O)C(CC[C@H](N)C(O)=O)=C1 VEVRNHHLCPGNDU-MUGJNUQGSA-O 0.000 claims description 16
• 239000008194 pharmaceutical composition Substances 0.000 claims description 14
• 229910052760 oxygen Inorganic materials 0.000 claims description 13
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 11
• 206010012601 diabetes mellitus Diseases 0.000 claims description 11
• 239000001301 oxygen Substances 0.000 claims description 11
• 229910052717 sulfur Inorganic materials 0.000 claims description 10
• 125000000732 arylene group Chemical group 0.000 claims description 8
• 125000004432 carbon atom Chemical group C* 0.000 claims description 8
• 239000003814 drug Substances 0.000 claims description 8
• 150000002430 hydrocarbons Chemical class 0.000 claims description 8
• 230000009471 action Effects 0.000 claims description 7
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 6
• 239000003937 drug carrier Substances 0.000 claims description 6
• 125000005549 heteroarylene group Chemical group 0.000 claims description 6
• 238000004519 manufacturing process Methods 0.000 claims description 6
• 239000011593 sulfur Substances 0.000 claims description 6
• 125000003831 tetrazolyl group Chemical group 0.000 claims description 6
• 239000004215 Carbon black (E152) Substances 0.000 claims description 4
• 229930195733 hydrocarbon Natural products 0.000 claims description 4
• 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims description 4
• 125000002373 5 membered heterocyclic group Chemical group 0.000 claims description 2
• 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 2
• 125000001183 hydrocarbyl group Chemical group 0.000 claims 2
• 125000003341 7 membered heterocyclic group Chemical group 0.000 claims 1
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 146
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 145
• 239000000203 mixture Substances 0.000 description 117
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 106
• 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 70
• JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 65
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 62
• 238000000034 method Methods 0.000 description 59
• 238000005160 1H NMR spectroscopy Methods 0.000 description 58
• 239000000243 solution Substances 0.000 description 58
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 54
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 52
• 230000015572 biosynthetic process Effects 0.000 description 51
• 238000003786 synthesis reaction Methods 0.000 description 51
• IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 50
• 239000011734 sodium Substances 0.000 description 49
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 48
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 47
• 150000001875 compounds Chemical class 0.000 description 47
• DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 47
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 46
• IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 44
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 42
• SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 37
• 235000019439 ethyl acetate Nutrition 0.000 description 37
• 239000000872 buffer Substances 0.000 description 36
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 35
• 238000007429 general method Methods 0.000 description 35
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 33
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 32
• 125000000539 amino acid group Chemical group 0.000 description 32
• 239000000047 product Substances 0.000 description 32
• 239000002904 solvent Substances 0.000 description 32
• 239000012074 organic phase Substances 0.000 description 31
• 239000007787 solid Substances 0.000 description 30
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 29
• 239000003921 oil Substances 0.000 description 27
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 26
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 25
• 238000004128 high performance liquid chromatography Methods 0.000 description 23
• 238000006243 chemical reaction Methods 0.000 description 22
• 239000012043 crude product Substances 0.000 description 22
• 239000000523 sample Substances 0.000 description 22
• 210000004027 cell Anatomy 0.000 description 18
• 238000000746 purification Methods 0.000 description 18
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 17
• 239000000706 filtrate Substances 0.000 description 17
• 239000002244 precipitate Substances 0.000 description 17
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 16
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 15
• 238000003818 flash chromatography Methods 0.000 description 15
• 108090000765 processed proteins & peptides Proteins 0.000 description 15
• 108091028043 Nucleic acid sequence Proteins 0.000 description 14
• DBNQIOANXZVWIP-UHFFFAOYSA-N n,n-dimethyl-1,1-bis[(2-methylpropan-2-yl)oxy]methanamine Chemical compound CC(C)(C)OC(N(C)C)OC(C)(C)C DBNQIOANXZVWIP-UHFFFAOYSA-N 0.000 description 14
• 239000011541 reaction mixture Substances 0.000 description 14
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 13
• 239000007983 Tris buffer Substances 0.000 description 13
• 229920005989 resin Polymers 0.000 description 13
• 239000011347 resin Substances 0.000 description 13
• 238000004007 reversed phase HPLC Methods 0.000 description 13
• 239000013598 vector Substances 0.000 description 13
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 12
• 238000005119 centrifugation Methods 0.000 description 12
• 239000000377 silicon dioxide Substances 0.000 description 12
• 238000001816 cooling Methods 0.000 description 11
• 150000002148 esters Chemical class 0.000 description 11
• 125000000896 monocarboxylic acid group Chemical group 0.000 description 11
• 230000007935 neutral effect Effects 0.000 description 11
• 239000000725 suspension Substances 0.000 description 11
• GOUHYARYYWKXHS-UHFFFAOYSA-N 4-formylbenzoic acid Chemical compound OC(=O)C1=CC=C(C=O)C=C1 GOUHYARYYWKXHS-UHFFFAOYSA-N 0.000 description 10
• 239000012267 brine Substances 0.000 description 10
• 238000001914 filtration Methods 0.000 description 10
• 239000012071 phase Substances 0.000 description 10
• HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 10
• 238000003756 stirring Methods 0.000 description 10
• 150000001413 amino acids Chemical class 0.000 description 9
• 239000007951 isotonicity adjuster Substances 0.000 description 9
• 239000003755 preservative agent Substances 0.000 description 9
• 238000010992 reflux Methods 0.000 description 9
• FPIRBHDGWMWJEP-UHFFFAOYSA-N 1-hydroxy-7-azabenzotriazole Chemical compound C1=CN=C2N(O)N=NC2=C1 FPIRBHDGWMWJEP-UHFFFAOYSA-N 0.000 description 8
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
• 229960000583 acetic acid Drugs 0.000 description 8
• 230000010933 acylation Effects 0.000 description 8
• 238000005917 acylation reaction Methods 0.000 description 8
• 229940024606 amino acid Drugs 0.000 description 8
• 235000001014 amino acid Nutrition 0.000 description 8
• 125000003118 aryl group Chemical group 0.000 description 8
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 8
• 239000013078 crystal Substances 0.000 description 8
• 201000001421 hyperglycemia Diseases 0.000 description 8
• 239000011701 zinc Substances 0.000 description 8
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 7
• 238000005481 NMR spectroscopy Methods 0.000 description 7
• KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 7
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 7
• 239000013058 crude material Substances 0.000 description 7
• 235000014113 dietary fatty acids Nutrition 0.000 description 7
• 239000000194 fatty acid Substances 0.000 description 7
• 229930195729 fatty acid Natural products 0.000 description 7
• 230000008569 process Effects 0.000 description 7
• 229920006395 saturated elastomer Polymers 0.000 description 7
• 125000001424 substituent group Chemical group 0.000 description 7
• 150000005846 sugar alcohols Chemical class 0.000 description 7
• 238000004809 thin layer chromatography Methods 0.000 description 7
• 208000001072 type 2 diabetes mellitus Diseases 0.000 description 7
• LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 6
• DIESMWGUDLUNEJ-UHFFFAOYSA-N 4-[[[3-[(2-methylpropan-2-yl)oxy]-3-oxopropyl]amino]methyl]benzoic acid Chemical compound CC(C)(C)OC(=O)CCNCC1=CC=C(C(O)=O)C=C1 DIESMWGUDLUNEJ-UHFFFAOYSA-N 0.000 description 6
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 6
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
• 239000012230 colorless oil Substances 0.000 description 6
• UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 6
• 239000003480 eluent Substances 0.000 description 6
• 150000004665 fatty acids Chemical class 0.000 description 6
• 238000001906 matrix-assisted laser desorption--ionisation mass spectrometry Methods 0.000 description 6
• 239000002609 medium Substances 0.000 description 6
• 238000001556 precipitation Methods 0.000 description 6
• 238000002953 preparative HPLC Methods 0.000 description 6
• 102000004196 processed proteins & peptides Human genes 0.000 description 6
• 108090000623 proteins and genes Proteins 0.000 description 6
• 230000003248 secreting effect Effects 0.000 description 6
• UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 6
• 235000000346 sugar Nutrition 0.000 description 6
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 5
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 5
• 108010076504 Protein Sorting Signals Proteins 0.000 description 5
• 239000002253 acid Substances 0.000 description 5
• 230000002378 acidificating effect Effects 0.000 description 5
• 125000003277 amino group Chemical group 0.000 description 5
• 125000002843 carboxylic acid group Chemical group 0.000 description 5
• 238000002347 injection Methods 0.000 description 5
• 239000007924 injection Substances 0.000 description 5
• 229920001184 polypeptide Polymers 0.000 description 5
• 230000002335 preservative effect Effects 0.000 description 5
• UVFQIBACTBYBMJ-PMERELPUSA-N (4s)-5-[(2-methylpropan-2-yl)oxy]-4-[[4-[[[16-[(2-methylpropan-2-yl)oxy]-16-oxohexadecanoyl]amino]methyl]benzoyl]amino]-5-oxopentanoic acid Chemical compound CC(C)(C)OC(=O)CCCCCCCCCCCCCCC(=O)NCC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(=O)OC(C)(C)C)C=C1 UVFQIBACTBYBMJ-PMERELPUSA-N 0.000 description 4
• KNKRKFALVUDBJE-UHFFFAOYSA-N 1,2-dichloropropane Chemical compound CC(Cl)CCl KNKRKFALVUDBJE-UHFFFAOYSA-N 0.000 description 4
• RUJWQYZAHOPUQT-UHFFFAOYSA-N 1-o-tert-butyl 16-o-(2,5-dioxopyrrolidin-1-yl) hexadecanedioate Chemical compound CC(C)(C)OC(=O)CCCCCCCCCCCCCCC(=O)ON1C(=O)CCC1=O RUJWQYZAHOPUQT-UHFFFAOYSA-N 0.000 description 4
• HXJICNOLPKEOLU-UHFFFAOYSA-M 16-[(2-methylpropan-2-yl)oxy]-16-oxohexadecanoate Chemical compound CC(C)(C)OC(=O)CCCCCCCCCCCCCCC([O-])=O HXJICNOLPKEOLU-UHFFFAOYSA-M 0.000 description 4
• HXJICNOLPKEOLU-UHFFFAOYSA-N 16-[(2-methylpropan-2-yl)oxy]-16-oxohexadecanoic acid Chemical compound CC(C)(C)OC(=O)CCCCCCCCCCCCCCC(O)=O HXJICNOLPKEOLU-UHFFFAOYSA-N 0.000 description 4
• KCUYTEIVSXQFKX-UHFFFAOYSA-N 17-[(2-methylpropan-2-yl)oxy]-17-oxoheptadecanoic acid Chemical compound CC(C)(C)OC(=O)CCCCCCCCCCCCCCCC(O)=O KCUYTEIVSXQFKX-UHFFFAOYSA-N 0.000 description 4
• IKRNLQVCIJPDTN-UHFFFAOYSA-N 3-[(2-methylpropan-2-yl)oxycarbonyl]-4-nitrobenzoic acid Chemical compound CC(C)(C)OC(=O)C1=CC(C(O)=O)=CC=C1[N+]([O-])=O IKRNLQVCIJPDTN-UHFFFAOYSA-N 0.000 description 4
• JLCBDWLQRGYNHY-UHFFFAOYSA-N 3-[(2-methylpropan-2-yl)oxycarbonyl]-5-[[2-[[18-[(2-methylpropan-2-yl)oxy]-18-oxooctadecanoyl]-[3-[(2-methylpropan-2-yl)oxy]-3-oxopropyl]amino]acetyl]amino]benzoic acid Chemical compound CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCC(=O)N(CCC(=O)OC(C)(C)C)CC(=O)NC1=CC(C(O)=O)=CC(C(=O)OC(C)(C)C)=C1 JLCBDWLQRGYNHY-UHFFFAOYSA-N 0.000 description 4
• 239000005711 Benzoic acid Substances 0.000 description 4
• KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical group C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 4
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
• 108010092217 Long-Acting Insulin Proteins 0.000 description 4
• 102000016261 Long-Acting Insulin Human genes 0.000 description 4
• 229940100066 Long-acting insulin Drugs 0.000 description 4
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
• 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 4
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
• 239000000654 additive Substances 0.000 description 4
• 239000003472 antidiabetic agent Substances 0.000 description 4
• 239000008346 aqueous phase Substances 0.000 description 4
• 235000010233 benzoic acid Nutrition 0.000 description 4
• 239000003153 chemical reaction reagent Substances 0.000 description 4
• 238000004587 chromatography analysis Methods 0.000 description 4
• 230000008878 coupling Effects 0.000 description 4
• 238000010168 coupling process Methods 0.000 description 4
• 238000005859 coupling reaction Methods 0.000 description 4
• 238000000105 evaporative light scattering detection Methods 0.000 description 4
• 125000005313 fatty acid group Chemical group 0.000 description 4
• 238000009472 formulation Methods 0.000 description 4
• YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 4
• 125000005842 heteroatom Chemical group 0.000 description 4
• 125000000623 heterocyclic group Chemical group 0.000 description 4
• QQHJDPROMQRDLA-UHFFFAOYSA-N hexadecanedioic acid Chemical compound OC(=O)CCCCCCCCCCCCCCC(O)=O QQHJDPROMQRDLA-UHFFFAOYSA-N 0.000 description 4
• 230000002209 hydrophobic effect Effects 0.000 description 4
• 239000003112 inhibitor Substances 0.000 description 4
• 150000002500 ions Chemical class 0.000 description 4
• RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 description 4
• 239000000463 material Substances 0.000 description 4
• DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
• 239000012044 organic layer Substances 0.000 description 4
• IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 description 4
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
• 230000002035 prolonged effect Effects 0.000 description 4
• 239000011780 sodium chloride Substances 0.000 description 4
• 239000006188 syrup Substances 0.000 description 4
• 235000020357 syrup Nutrition 0.000 description 4
• 229910052725 zinc Inorganic materials 0.000 description 4
• NDIJXLKQGQLPQC-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 4-[[[16-[(2-methylpropan-2-yl)oxy]-16-oxohexadecanoyl]-[3-[(2-methylpropan-2-yl)oxy]-3-oxopropyl]amino]methyl]benzoate Chemical compound C1=CC(CN(CCC(=O)OC(C)(C)C)C(=O)CCCCCCCCCCCCCCC(=O)OC(C)(C)C)=CC=C1C(=O)ON1C(=O)CCC1=O NDIJXLKQGQLPQC-UHFFFAOYSA-N 0.000 description 3
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
• GOPWHXPXSPIIQZ-HXUWFJFHSA-N (4r)-4-(9h-fluoren-9-ylmethoxycarbonylamino)-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@H](CCC(O)=O)C(=O)OC(C)(C)C)C3=CC=CC=C3C2=C1 GOPWHXPXSPIIQZ-HXUWFJFHSA-N 0.000 description 3
• ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 3
• FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 3
• AXDZWMCZHUPJDF-UHFFFAOYSA-N 3-[(2-methylpropan-2-yl)oxycarbonyl]-4-[[16-[(2-methylpropan-2-yl)oxy]-16-oxohexadecanoyl]amino]benzoic acid Chemical compound CC(C)(C)OC(=O)CCCCCCCCCCCCCCC(=O)NC1=CC=C(C(O)=O)C=C1C(=O)OC(C)(C)C AXDZWMCZHUPJDF-UHFFFAOYSA-N 0.000 description 3
• JRUWCTHPURKCQD-UHFFFAOYSA-N 3-[4-[4-[3-[(2-methylpropan-2-yl)oxy]-3-oxopropyl]phenyl]phenyl]propanoic acid Chemical compound C1=CC(CCC(=O)OC(C)(C)C)=CC=C1C1=CC=C(CCC(O)=O)C=C1 JRUWCTHPURKCQD-UHFFFAOYSA-N 0.000 description 3
• CYDCKSFBUAJOKM-UHFFFAOYSA-N 3-[[[3-[(2-methylpropan-2-yl)oxy]-3-oxopropyl]amino]methyl]benzoic acid Chemical compound CC(C)(C)OC(=O)CCNCC1=CC=CC(C(O)=O)=C1 CYDCKSFBUAJOKM-UHFFFAOYSA-N 0.000 description 3
• QKIWEAOLQPBYPB-UHFFFAOYSA-N 4-[[[16-[(2-methylpropan-2-yl)oxy]-16-oxohexadecanoyl]amino]methyl]benzoic acid Chemical compound CC(C)(C)OC(=O)CCCCCCCCCCCCCCC(=O)NCC1=CC=C(C(O)=O)C=C1 QKIWEAOLQPBYPB-UHFFFAOYSA-N 0.000 description 3
• WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
• YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
• DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 description 3
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 3
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 3
• 229930195725 Mannitol Natural products 0.000 description 3
• 239000012901 Milli-Q water Substances 0.000 description 3
• 125000000729 N-terminal amino-acid group Chemical group 0.000 description 3
• 108010005991 Pork Regular Insulin Proteins 0.000 description 3
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
• 238000004458 analytical method Methods 0.000 description 3
• UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 3
• 239000006172 buffering agent Substances 0.000 description 3
• 229910052799 carbon Inorganic materials 0.000 description 3
• 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
• 238000010790 dilution Methods 0.000 description 3
• 239000012895 dilution Substances 0.000 description 3
• 229940079593 drug Drugs 0.000 description 3
• 235000011187 glycerol Nutrition 0.000 description 3
• 238000010438 heat treatment Methods 0.000 description 3
• 229910052739 hydrogen Inorganic materials 0.000 description 3
• NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 3
• 239000000594 mannitol Substances 0.000 description 3
• 235000010355 mannitol Nutrition 0.000 description 3
• VXJIGUJXWZEJCK-UHFFFAOYSA-N methyl 4-[[16-[(2-methylpropan-2-yl)oxy]-16-oxohexadecanoyl]amino]benzoate Chemical compound COC(=O)C1=CC=C(NC(=O)CCCCCCCCCCCCCCC(=O)OC(C)(C)C)C=C1 VXJIGUJXWZEJCK-UHFFFAOYSA-N 0.000 description 3
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
• VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
• QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 3
• 229910052763 palladium Inorganic materials 0.000 description 3
• 239000002245 particle Substances 0.000 description 3
• 238000005191 phase separation Methods 0.000 description 3
• 239000000843 powder Substances 0.000 description 3
• 239000002243 precursor Substances 0.000 description 3
• 235000018102 proteins Nutrition 0.000 description 3
• 102000004169 proteins and genes Human genes 0.000 description 3
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
• 125000005551 pyridylene group Chemical group 0.000 description 3
• 230000010076 replication Effects 0.000 description 3
• 229910052708 sodium Inorganic materials 0.000 description 3
• BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 3
• 239000007858 starting material Substances 0.000 description 3
• RLCMGTZVFCCFHP-UHFFFAOYSA-N tert-butyl 15-bromopentadecanoate Chemical compound CC(C)(C)OC(=O)CCCCCCCCCCCCCCBr RLCMGTZVFCCFHP-UHFFFAOYSA-N 0.000 description 3
• 238000013518 transcription Methods 0.000 description 3
• 230000035897 transcription Effects 0.000 description 3
• 239000003643 water by type Substances 0.000 description 3
• PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
• LQFLVWJAZJBBIT-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 2-[[[16-[(2-methylpropan-2-yl)oxy]-16-oxohexadecanoyl]-[3-[(2-methylpropan-2-yl)oxy]-3-oxopropyl]amino]methyl]benzoate Chemical compound CC(C)(C)OC(=O)CCCCCCCCCCCCCCC(=O)N(CCC(=O)OC(C)(C)C)CC1=CC=CC=C1C(=O)ON1C(=O)CCC1=O LQFLVWJAZJBBIT-UHFFFAOYSA-N 0.000 description 2
• DVRXACSLOKPULM-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-[[[16-[(2-methylpropan-2-yl)oxy]-16-oxohexadecanoyl]-[3-[(2-methylpropan-2-yl)oxy]-3-oxopropyl]amino]methyl]benzoate Chemical compound CC(C)(C)OC(=O)CCCCCCCCCCCCCCC(=O)N(CCC(=O)OC(C)(C)C)CC1=CC=CC(C(=O)ON2C(CCC2=O)=O)=C1 DVRXACSLOKPULM-UHFFFAOYSA-N 0.000 description 2
• GHUXHCJXEZZFIB-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 4-[[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-[16-[(2-methylpropan-2-yl)oxy]-16-oxohexadecanoyl]amino]benzoate Chemical compound C1=CC(N(CC(=O)OC(C)(C)C)C(=O)CCCCCCCCCCCCCCC(=O)OC(C)(C)C)=CC=C1C(=O)ON1C(=O)CCC1=O GHUXHCJXEZZFIB-UHFFFAOYSA-N 0.000 description 2
• VOAIUKWQRRHUBI-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 4-[[[17-[(2-methylpropan-2-yl)oxy]-17-oxoheptadecanoyl]-[3-[(2-methylpropan-2-yl)oxy]-3-oxopropyl]amino]methyl]benzoate Chemical compound C1=CC(CN(CCC(=O)OC(C)(C)C)C(=O)CCCCCCCCCCCCCCCC(=O)OC(C)(C)C)=CC=C1C(=O)ON1C(=O)CCC1=O VOAIUKWQRRHUBI-UHFFFAOYSA-N 0.000 description 2
• QVAQMUAKTNUNLN-LURJTMIESA-N (4s)-4-amino-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoic acid Chemical compound CC(C)(C)OC(=O)[C@@H](N)CCC(O)=O QVAQMUAKTNUNLN-LURJTMIESA-N 0.000 description 2
• BDNKZNFMNDZQMI-UHFFFAOYSA-N 1,3-diisopropylcarbodiimide Chemical compound CC(C)N=C=NC(C)C BDNKZNFMNDZQMI-UHFFFAOYSA-N 0.000 description 2
• RMANXVIVIQXJPI-UHFFFAOYSA-N 1-o-tert-butyl 3-o-(2,5-dioxopyrrolidin-1-yl) 5-[[2-[[18-[(2-methylpropan-2-yl)oxy]-18-oxooctadecanoyl]-[3-[(2-methylpropan-2-yl)oxy]-3-oxopropyl]amino]acetyl]amino]benzene-1,3-dicarboxylate Chemical compound CC(C)(C)OC(=O)C1=CC(NC(=O)CN(CCC(=O)OC(C)(C)C)C(=O)CCCCCCCCCCCCCCCCC(=O)OC(C)(C)C)=CC(C(=O)ON2C(CCC2=O)=O)=C1 RMANXVIVIQXJPI-UHFFFAOYSA-N 0.000 description 2
• JVXZLYHNDFALNK-UHFFFAOYSA-N 1-o-tert-butyl 5-o-(2,5-dioxopyrrolidin-1-yl) 2-[10-[4-[(2-methylpropan-2-yl)oxycarbonyl]phenoxy]decanoylamino]pentanedioate Chemical compound C=1C=C(C(=O)OC(C)(C)C)C=CC=1OCCCCCCCCCC(=O)NC(C(=O)OC(C)(C)C)CCC(=O)ON1C(=O)CCC1=O JVXZLYHNDFALNK-UHFFFAOYSA-N 0.000 description 2
• OLACPKKVZSLCSI-UHFFFAOYSA-N 15-bromopentadecanoic acid Chemical compound OC(=O)CCCCCCCCCCCCCCBr OLACPKKVZSLCSI-UHFFFAOYSA-N 0.000 description 2
• OVBRKVHQENVNOG-UHFFFAOYSA-N 16-[(4-methoxyphenyl)methoxy]-16-oxohexadecanoic acid Chemical compound COC1=CC=C(COC(=O)CCCCCCCCCCCCCCC(O)=O)C=C1 OVBRKVHQENVNOG-UHFFFAOYSA-N 0.000 description 2
• VGAMGQWFDUYFOU-UHFFFAOYSA-N 17-methoxy-16-methoxycarbonyl-17-oxoheptadecanoic acid Chemical compound COC(=O)C(C(=O)OC)CCCCCCCCCCCCCCC(O)=O VGAMGQWFDUYFOU-UHFFFAOYSA-N 0.000 description 2
• XXMFJKNOJSDQBM-UHFFFAOYSA-N 2,2,2-trifluoroacetic acid;hydrate Chemical compound [OH3+].[O-]C(=O)C(F)(F)F XXMFJKNOJSDQBM-UHFFFAOYSA-N 0.000 description 2
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
• UFBZYFFEIDRMFR-UHFFFAOYSA-N 2-[[18-[(2-methylpropan-2-yl)oxy]-18-oxooctadecanoyl]-[3-[(2-methylpropan-2-yl)oxy]-3-oxopropyl]amino]acetic acid Chemical compound CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCC(=O)N(CC(O)=O)CCC(=O)OC(C)(C)C UFBZYFFEIDRMFR-UHFFFAOYSA-N 0.000 description 2
• CZOXFXASSDRWTD-UHFFFAOYSA-N 2-[[[3-[(2-methylpropan-2-yl)oxy]-3-oxopropyl]amino]methyl]benzoic acid Chemical compound CC(C)(C)OC(=O)CCNCC1=CC=CC=C1C(O)=O CZOXFXASSDRWTD-UHFFFAOYSA-N 0.000 description 2
• SMNDYUVBFMFKNZ-UHFFFAOYSA-N 2-furoic acid Chemical compound OC(=O)C1=CC=CO1 SMNDYUVBFMFKNZ-UHFFFAOYSA-N 0.000 description 2
• LIQLYTSJSBMCAH-UHFFFAOYSA-N 2-hydroxy-5-methoxycarbonylbenzoic acid Chemical compound COC(=O)C1=CC=C(O)C(C(O)=O)=C1 LIQLYTSJSBMCAH-UHFFFAOYSA-N 0.000 description 2
• WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
• LMYDMHLXJPQDKF-UHFFFAOYSA-N 3-[(2-methylpropan-2-yl)oxycarbonyl]-4-[15-[(2-methylpropan-2-yl)oxy]-15-oxopentadecoxy]benzoic acid Chemical compound CC(C)(C)OC(=O)CCCCCCCCCCCCCCOC1=CC=C(C(O)=O)C=C1C(=O)OC(C)(C)C LMYDMHLXJPQDKF-UHFFFAOYSA-N 0.000 description 2
• AAYPFDSEYNOZDR-UHFFFAOYSA-N 3-[(2-methylpropan-2-yl)oxycarbonyl]-5-[[16-[(2-methylpropan-2-yl)oxy]-16-oxohexadecanoyl]amino]benzoic acid Chemical compound CC(C)(C)OC(=O)CCCCCCCCCCCCCCC(=O)NC1=CC(C(O)=O)=CC(C(=O)OC(C)(C)C)=C1 AAYPFDSEYNOZDR-UHFFFAOYSA-N 0.000 description 2
• VKBYEGSAQFSFRE-UHFFFAOYSA-N 3-[[3,5-bis[2-[(2-methylpropan-2-yl)oxy]-2-oxoethoxy]phenyl]methyl-[16-[(4-methoxyphenyl)methoxy]-16-oxohexadecanoyl]amino]propanoic acid Chemical compound C1=CC(OC)=CC=C1COC(=O)CCCCCCCCCCCCCCC(=O)N(CCC(O)=O)CC1=CC(OCC(=O)OC(C)(C)C)=CC(OCC(=O)OC(C)(C)C)=C1 VKBYEGSAQFSFRE-UHFFFAOYSA-N 0.000 description 2
• WINMNGOGWBRUOL-UHFFFAOYSA-N 3-[[3,5-bis[2-[(2-methylpropan-2-yl)oxy]-2-oxoethoxy]phenyl]methylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)COC1=CC(CNCCC(O)=O)=CC(OCC(=O)OC(C)(C)C)=C1 WINMNGOGWBRUOL-UHFFFAOYSA-N 0.000 description 2
• AVJKNHSOHBSOAG-UHFFFAOYSA-N 3-[[[16-[(2-methylpropan-2-yl)oxy]-16-oxohexadecanoyl]-[3-[(2-methylpropan-2-yl)oxy]-3-oxopropyl]amino]methyl]benzoic acid Chemical compound CC(C)(C)OC(=O)CCCCCCCCCCCCCCC(=O)N(CCC(=O)OC(C)(C)C)CC1=CC=CC(C(O)=O)=C1 AVJKNHSOHBSOAG-UHFFFAOYSA-N 0.000 description 2
• ZFSWETRVBAFNRS-UHFFFAOYSA-N 3-amino-5-[(2-methylpropan-2-yl)oxycarbonyl]benzoic acid Chemical compound CC(C)(C)OC(=O)C1=CC(N)=CC(C(O)=O)=C1 ZFSWETRVBAFNRS-UHFFFAOYSA-N 0.000 description 2
• DPJYGTACPSHQLB-UHFFFAOYSA-N 3-o-tert-butyl 1-o-(2,5-dioxopyrrolidin-1-yl) 4-[15-[(2-methylpropan-2-yl)oxy]-15-oxopentadecoxy]benzene-1,3-dicarboxylate Chemical compound C1=C(C(=O)OC(C)(C)C)C(OCCCCCCCCCCCCCCC(=O)OC(C)(C)C)=CC=C1C(=O)ON1C(=O)CCC1=O DPJYGTACPSHQLB-UHFFFAOYSA-N 0.000 description 2
• IORYHMZOHHNWAU-UHFFFAOYSA-N 3-o-tert-butyl 1-o-(2,5-dioxopyrrolidin-1-yl) 4-[[16-[(2-methylpropan-2-yl)oxy]-16-oxohexadecanoyl]amino]benzene-1,3-dicarboxylate Chemical compound C1=C(C(=O)OC(C)(C)C)C(NC(=O)CCCCCCCCCCCCCCC(=O)OC(C)(C)C)=CC=C1C(=O)ON1C(=O)CCC1=O IORYHMZOHHNWAU-UHFFFAOYSA-N 0.000 description 2
• SDMFXSUUWQTWFX-UHFFFAOYSA-N 3-o-tert-butyl 1-o-methyl 4-[15-[(2-methylpropan-2-yl)oxy]-15-oxopentadecoxy]benzene-1,3-dicarboxylate Chemical compound COC(=O)C1=CC=C(OCCCCCCCCCCCCCCC(=O)OC(C)(C)C)C(C(=O)OC(C)(C)C)=C1 SDMFXSUUWQTWFX-UHFFFAOYSA-N 0.000 description 2
• LKBDLZVBBGMIFK-UHFFFAOYSA-N 3-o-tert-butyl 1-o-methyl 4-hydroxybenzene-1,3-dicarboxylate Chemical compound COC(=O)C1=CC=C(O)C(C(=O)OC(C)(C)C)=C1 LKBDLZVBBGMIFK-UHFFFAOYSA-N 0.000 description 2
• BRMKORAZORQXMU-UHFFFAOYSA-N 4-[[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-[16-[(2-methylpropan-2-yl)oxy]-16-oxohexadecanoyl]amino]benzoic acid Chemical compound CC(C)(C)OC(=O)CCCCCCCCCCCCCCC(=O)N(CC(=O)OC(C)(C)C)C1=CC=C(C(O)=O)C=C1 BRMKORAZORQXMU-UHFFFAOYSA-N 0.000 description 2
• IQELAIKRQNABLW-UHFFFAOYSA-N 4-[[[16-[(2-methylpropan-2-yl)oxy]-16-oxohexadecanoyl]-[3-[(2-methylpropan-2-yl)oxy]-3-oxopropyl]amino]methyl]benzoic acid Chemical compound CC(C)(C)OC(=O)CCCCCCCCCCCCCCC(=O)N(CCC(=O)OC(C)(C)C)CC1=CC=C(C(O)=O)C=C1 IQELAIKRQNABLW-UHFFFAOYSA-N 0.000 description 2
• PXRYTXOEZZWXMR-UHFFFAOYSA-N 4-amino-3-[(2-methylpropan-2-yl)oxycarbonyl]benzoic acid Chemical compound CC(C)(C)OC(=O)C1=CC(C(O)=O)=CC=C1N PXRYTXOEZZWXMR-UHFFFAOYSA-N 0.000 description 2
• CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 description 2
• BCEQKAQCUWUNML-UHFFFAOYSA-N 4-hydroxybenzene-1,3-dicarboxylic acid Chemical compound OC(=O)C1=CC=C(O)C(C(O)=O)=C1 BCEQKAQCUWUNML-UHFFFAOYSA-N 0.000 description 2
• FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
• OCJFXVHDIVAONP-UHFFFAOYSA-N 4-nitroisophthalic acid Chemical compound OC(=O)C1=CC=C([N+]([O-])=O)C(C(O)=O)=C1 OCJFXVHDIVAONP-UHFFFAOYSA-N 0.000 description 2
• NIUHFEBDUNSDBG-UHFFFAOYSA-N 5-[(2-methylpropan-2-yl)oxycarbonyl]-2-nitrobenzoic acid Chemical compound CC(C)(C)OC(=O)C1=CC=C([N+]([O-])=O)C(C(O)=O)=C1 NIUHFEBDUNSDBG-UHFFFAOYSA-N 0.000 description 2
• LFXRZDSFFDWQEX-UHFFFAOYSA-N 5-[[[16-[(2-methylpropan-2-yl)oxy]-16-oxohexadecanoyl]-[3-[(2-methylpropan-2-yl)oxy]-3-oxopropyl]amino]methyl]furan-2-carboxylic acid Chemical compound CC(C)(C)OC(=O)CCCCCCCCCCCCCCC(=O)N(CCC(=O)OC(C)(C)C)CC1=CC=C(C(O)=O)O1 LFXRZDSFFDWQEX-UHFFFAOYSA-N 0.000 description 2
• NPWNLCXLHHKUIE-UHFFFAOYSA-N 5-o-benzyl 1-o-tert-butyl 2-[10-[4-[(2-methylpropan-2-yl)oxycarbonyl]phenoxy]decanoylamino]pentanedioate Chemical compound C=1C=C(C(=O)OC(C)(C)C)C=CC=1OCCCCCCCCCC(=O)NC(C(=O)OC(C)(C)C)CCC(=O)OCC1=CC=CC=C1 NPWNLCXLHHKUIE-UHFFFAOYSA-N 0.000 description 2
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
• USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
• 239000005695 Ammonium acetate Substances 0.000 description 2
• 239000004475 Arginine Substances 0.000 description 2
• 101001011741 Bos taurus Insulin Proteins 0.000 description 2
• WUFJYJFTZBNYDC-SANMLTNESA-N CC(C)(C)OC(=O)CC[C@@H](C(=O)ON1C(=O)CCC1=O)NC(=O)CCCCCCCCCSC2=CC=C(C=C2)C(=O)OC(C)(C)C Chemical compound CC(C)(C)OC(=O)CC[C@@H](C(=O)ON1C(=O)CCC1=O)NC(=O)CCCCCCCCCSC2=CC=C(C=C2)C(=O)OC(C)(C)C WUFJYJFTZBNYDC-SANMLTNESA-N 0.000 description 2
• SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
• 108020004414 DNA Proteins 0.000 description 2
• ALBUJVBOIXVVLS-UHFFFAOYSA-N Dimethyl 4-hydroxyisophthalate Chemical compound COC(=O)C1=CC=C(O)C(C(=O)OC)=C1 ALBUJVBOIXVVLS-UHFFFAOYSA-N 0.000 description 2
• 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 description 2
• VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
• 102000001267 GSK3 Human genes 0.000 description 2
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 2
• 101000930822 Giardia intestinalis Dipeptidyl-peptidase 4 Proteins 0.000 description 2
• 101800000224 Glucagon-like peptide 1 Proteins 0.000 description 2
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
• 239000004471 Glycine Substances 0.000 description 2
• 108010014905 Glycogen Synthase Kinase 3 Proteins 0.000 description 2
• 108010008488 Glycylglycine Proteins 0.000 description 2
• QCNWZROVPSVEJA-UHFFFAOYSA-N Heptadecanedioic acid Chemical compound OC(=O)CCCCCCCCCCCCCCCC(O)=O QCNWZROVPSVEJA-UHFFFAOYSA-N 0.000 description 2
• 101000852815 Homo sapiens Insulin receptor Proteins 0.000 description 2
• 125000000998 L-alanino group Chemical group [H]N([*])[C@](C([H])([H])[H])([H])C(=O)O[H] 0.000 description 2
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
• 239000004472 Lysine Substances 0.000 description 2
• BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
• 241000699670 Mus sp. Species 0.000 description 2
• SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 description 2
• 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 description 2
• 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 description 2
• NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
• 102100040918 Pro-glucagon Human genes 0.000 description 2
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
• VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical group [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
• 229930006000 Sucrose Natural products 0.000 description 2
• HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
• 239000008186 active pharmaceutical agent Substances 0.000 description 2
• 239000013543 active substance Substances 0.000 description 2
• 230000000996 additive effect Effects 0.000 description 2
• 239000000556 agonist Substances 0.000 description 2
• QCTBMLYLENLHLA-UHFFFAOYSA-N aminomethylbenzoic acid Chemical compound NCC1=CC=C(C(O)=O)C=C1 QCTBMLYLENLHLA-UHFFFAOYSA-N 0.000 description 2
• 235000019257 ammonium acetate Nutrition 0.000 description 2
• 229940043376 ammonium acetate Drugs 0.000 description 2
• BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
• 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
• 235000011130 ammonium sulphate Nutrition 0.000 description 2
• 229940125708 antidiabetic agent Drugs 0.000 description 2
• 239000003524 antilipemic agent Substances 0.000 description 2
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
• 235000003704 aspartic acid Nutrition 0.000 description 2
• 238000003556 assay Methods 0.000 description 2
• 239000011324 bead Substances 0.000 description 2
• FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 2
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
• 239000012148 binding buffer Substances 0.000 description 2
• SBCHWRVQWNNBCU-UHFFFAOYSA-N bis(2,5-dioxopyrrolidin-1-yl) 5-[15-[(2-methylpropan-2-yl)oxy]-15-oxopentadecoxy]benzene-1,3-dicarboxylate Chemical compound C=1C(OCCCCCCCCCCCCCCC(=O)OC(C)(C)C)=CC(C(=O)ON2C(CCC2=O)=O)=CC=1C(=O)ON1C(=O)CCC1=O SBCHWRVQWNNBCU-UHFFFAOYSA-N 0.000 description 2
• IXIBAKNTJSCKJM-BUBXBXGNSA-N bovine insulin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 IXIBAKNTJSCKJM-BUBXBXGNSA-N 0.000 description 2
• 125000002837 carbocyclic group Chemical group 0.000 description 2
• 239000003795 chemical substances by application Substances 0.000 description 2
• OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
• 239000002299 complementary DNA Substances 0.000 description 2
• 238000011109 contamination Methods 0.000 description 2
• 238000007796 conventional method Methods 0.000 description 2
• 125000004122 cyclic group Chemical group 0.000 description 2
• GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
• 238000010511 deprotection reaction Methods 0.000 description 2
• 238000001514 detection method Methods 0.000 description 2
• 229940043279 diisopropylamine Drugs 0.000 description 2
• BGRWYRAHAFMIBJ-UHFFFAOYSA-N diisopropylcarbodiimide Natural products CC(C)NC(=O)NC(C)C BGRWYRAHAFMIBJ-UHFFFAOYSA-N 0.000 description 2
• NOQWODRQJSWZHE-UHFFFAOYSA-N dimethyl 5-[15-[(2-methylpropan-2-yl)oxy]-15-oxopentadecoxy]benzene-1,3-dicarboxylate Chemical compound COC(=O)C1=CC(OCCCCCCCCCCCCCCC(=O)OC(C)(C)C)=CC(C(=O)OC)=C1 NOQWODRQJSWZHE-UHFFFAOYSA-N 0.000 description 2
• XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
• POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
• 238000010828 elution Methods 0.000 description 2
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
• 238000004108 freeze drying Methods 0.000 description 2
• FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 2
• 239000011521 glass Substances 0.000 description 2
• 239000008103 glucose Substances 0.000 description 2
• 229940043257 glycylglycine Drugs 0.000 description 2
• KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 description 2
• IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
• 229960002885 histidine Drugs 0.000 description 2
• 102000047882 human INSR Human genes 0.000 description 2
• 239000001257 hydrogen Substances 0.000 description 2
• 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
• 239000012535 impurity Substances 0.000 description 2
• 239000004615 ingredient Substances 0.000 description 2
• CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
• 238000004255 ion exchange chromatography Methods 0.000 description 2
• QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical group OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 2
• 125000005647 linker group Chemical group 0.000 description 2
• 239000007788 liquid Substances 0.000 description 2
• 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 2
• 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 2
• 230000014759 maintenance of location Effects 0.000 description 2
• HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
• SHCRSWJVWSAMKQ-UHFFFAOYSA-N methyl 10-bromodecanoate Chemical compound COC(=O)CCCCCCCCCBr SHCRSWJVWSAMKQ-UHFFFAOYSA-N 0.000 description 2
• 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
• 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
• LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
• 238000010369 molecular cloning Methods 0.000 description 2
• 125000002950 monocyclic group Chemical group 0.000 description 2
• WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
• 239000002773 nucleotide Substances 0.000 description 2
• 125000003729 nucleotide group Chemical group 0.000 description 2
• QWVGKYWNOKOFNN-UHFFFAOYSA-N o-cresol Chemical compound CC1=CC=CC=C1O QWVGKYWNOKOFNN-UHFFFAOYSA-N 0.000 description 2
• 125000005564 oxazolylene group Chemical group 0.000 description 2
• 238000007911 parenteral administration Methods 0.000 description 2
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
• WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 2
• 229920001223 polyethylene glycol Polymers 0.000 description 2
• BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
• 235000013772 propylene glycol Nutrition 0.000 description 2
• 125000005576 pyrimidinylene group Chemical group 0.000 description 2
• 102000005962 receptors Human genes 0.000 description 2
• 108020003175 receptors Proteins 0.000 description 2
• 230000003362 replicative effect Effects 0.000 description 2
• 150000003839 salts Chemical class 0.000 description 2
• 238000002821 scintillation proximity assay Methods 0.000 description 2
• CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
• 239000002002 slurry Substances 0.000 description 2
• 239000001632 sodium acetate Substances 0.000 description 2
• 235000017281 sodium acetate Nutrition 0.000 description 2
• VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
• 239000001488 sodium phosphate Substances 0.000 description 2
• 229910000162 sodium phosphate Inorganic materials 0.000 description 2
• 235000011008 sodium phosphates Nutrition 0.000 description 2
• 238000010561 standard procedure Methods 0.000 description 2
• 238000006467 substitution reaction Methods 0.000 description 2
• 239000005720 sucrose Substances 0.000 description 2
• HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 description 2
• 239000006228 supernatant Substances 0.000 description 2
• XIEWUSWJDJLXRD-UHFFFAOYSA-N tert-butyl 2-[3-formyl-5-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethoxy]phenoxy]acetate Chemical compound CC(C)(C)OC(=O)COC1=CC(OCC(=O)OC(C)(C)C)=CC(C=O)=C1 XIEWUSWJDJLXRD-UHFFFAOYSA-N 0.000 description 2
• BNWCETAHAJSBFG-UHFFFAOYSA-N tert-butyl 2-bromoacetate Chemical compound CC(C)(C)OC(=O)CBr BNWCETAHAJSBFG-UHFFFAOYSA-N 0.000 description 2
• OOXMNZPYSWHBOB-UHFFFAOYSA-N tert-butyl 3-(4-bromophenyl)propanoate Chemical compound CC(C)(C)OC(=O)CCC1=CC=C(Br)C=C1 OOXMNZPYSWHBOB-UHFFFAOYSA-N 0.000 description 2
• WHWMOMRHHQLBQQ-UHFFFAOYSA-N tert-butyl 4-hydroxybenzoate Chemical compound CC(C)(C)OC(=O)C1=CC=C(O)C=C1 WHWMOMRHHQLBQQ-UHFFFAOYSA-N 0.000 description 2
• 238000002560 therapeutic procedure Methods 0.000 description 2
• 125000005557 thiazolylene group Chemical group 0.000 description 2
• 125000005556 thienylene group Chemical group 0.000 description 2
• FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
• 210000001519 tissue Anatomy 0.000 description 2
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
• HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
• DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
• UPQNXRZQDZLTLD-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 4-[[[15-[(2-methylpropan-2-yl)oxy]-15-oxopentadecanoyl]-[3-[(2-methylpropan-2-yl)oxy]-3-oxopropyl]amino]methyl]benzoate Chemical compound C1=CC(CN(CCC(=O)OC(C)(C)C)C(=O)CCCCCCCCCCCCCC(=O)OC(C)(C)C)=CC=C1C(=O)ON1C(=O)CCC1=O UPQNXRZQDZLTLD-UHFFFAOYSA-N 0.000 description 1
• GOUCLDGTQFTIQU-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 4-[[[18-[(2-methylpropan-2-yl)oxy]-18-oxooctadecanoyl]-[3-[(2-methylpropan-2-yl)oxy]-3-oxopropyl]amino]methyl]benzoate Chemical compound C1=CC(CN(CCC(=O)OC(C)(C)C)C(=O)CCCCCCCCCCCCCCCCC(=O)OC(C)(C)C)=CC=C1C(=O)ON1C(=O)CCC1=O GOUCLDGTQFTIQU-UHFFFAOYSA-N 0.000 description 1
• LQEPGOAOWOAKMT-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 5-[[[16-[(2-methylpropan-2-yl)oxy]-16-oxohexadecanoyl]-[3-[(2-methylpropan-2-yl)oxy]-3-oxopropyl]amino]methyl]furan-2-carboxylate Chemical compound O1C(CN(CCC(=O)OC(C)(C)C)C(=O)CCCCCCCCCCCCCCC(=O)OC(C)(C)C)=CC=C1C(=O)ON1C(=O)CCC1=O LQEPGOAOWOAKMT-UHFFFAOYSA-N 0.000 description 1
• NSMLJDWFQLPLNL-QHCPKHFHSA-N (3S)-4-[(2-methylpropan-2-yl)oxy]-3-[10-[4-[(2-methylpropan-2-yl)oxycarbonyl]phenoxy]decanoylamino]-4-oxobutanoic acid Chemical compound CC(C)(C)OC(=O)[C@H](CC(O)=O)NC(=O)CCCCCCCCCOC1=CC=C(C(=O)OC(C)(C)C)C=C1 NSMLJDWFQLPLNL-QHCPKHFHSA-N 0.000 description 1
• PUWCNJZIFKBDJQ-YFKPBYRVSA-N (3s)-3-azaniumyl-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoate Chemical compound CC(C)(C)OC(=O)[C@@H](N)CC(O)=O PUWCNJZIFKBDJQ-YFKPBYRVSA-N 0.000 description 1
• DDWUOOZVINDGON-UHFFFAOYSA-N (4-methoxyphenyl)methyl 16-[[3,5-bis[2-[(2-methylpropan-2-yl)oxy]-2-oxoethoxy]phenyl]methyl-[3-(2,5-dioxopyrrolidin-1-yl)oxy-3-oxopropyl]amino]-16-oxohexadecanoate Chemical compound C1=CC(OC)=CC=C1COC(=O)CCCCCCCCCCCCCCC(=O)N(CC=1C=C(OCC(=O)OC(C)(C)C)C=C(OCC(=O)OC(C)(C)C)C=1)CCC(=O)ON1C(=O)CCC1=O DDWUOOZVINDGON-UHFFFAOYSA-N 0.000 description 1
• UVFQIBACTBYBMJ-SSEXGKCCSA-N (4r)-5-[(2-methylpropan-2-yl)oxy]-4-[[4-[[[16-[(2-methylpropan-2-yl)oxy]-16-oxohexadecanoyl]amino]methyl]benzoyl]amino]-5-oxopentanoic acid Chemical compound CC(C)(C)OC(=O)CCCCCCCCCCCCCCC(=O)NCC1=CC=C(C(=O)N[C@H](CCC(O)=O)C(=O)OC(C)(C)C)C=C1 UVFQIBACTBYBMJ-SSEXGKCCSA-N 0.000 description 1
• QVDCGOSWAHBRCZ-VWLOTQADSA-N (4s)-5-[(2-methylpropan-2-yl)oxy]-4-[11-[4-[(2-methylpropan-2-yl)oxycarbonyl]phenoxy]undecanoylamino]-5-oxopentanoic acid Chemical compound CC(C)(C)OC(=O)[C@H](CCC(O)=O)NC(=O)CCCCCCCCCCOC1=CC=C(C(=O)OC(C)(C)C)C=C1 QVDCGOSWAHBRCZ-VWLOTQADSA-N 0.000 description 1
• HMBLHIDWPXPBRR-VWLOTQADSA-N (4s)-5-[(2-methylpropan-2-yl)oxy]-4-[11-[4-[(2-methylpropan-2-yl)oxycarbonyl]phenyl]sulfanylundecanoylamino]-5-oxopentanoic acid Chemical compound CC(C)(C)OC(=O)[C@H](CCC(O)=O)NC(=O)CCCCCCCCCCSC1=CC=C(C(=O)OC(C)(C)C)C=C1 HMBLHIDWPXPBRR-VWLOTQADSA-N 0.000 description 1
• DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
• BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
• FFEKJBVVAJTQST-WLHGVMLRSA-N (e)-but-2-enedioic acid;1,1-dimethyl-2-(2-morpholin-4-ylphenyl)guanidine Chemical compound OC(=O)\C=C\C(O)=O.CN(C)C(N)=NC1=CC=CC=C1N1CCOCC1 FFEKJBVVAJTQST-WLHGVMLRSA-N 0.000 description 1
• 150000000180 1,2-diols Chemical class 0.000 description 1
• YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
• MOHYOXXOKFQHDC-UHFFFAOYSA-N 1-(chloromethyl)-4-methoxybenzene Chemical compound COC1=CC=C(CCl)C=C1 MOHYOXXOKFQHDC-UHFFFAOYSA-N 0.000 description 1
• OZNXGCWWPFTBMA-MHZLTWQESA-N 1-o-tert-butyl 5-o-(2,5-dioxopyrrolidin-1-yl) (2s)-2-[11-[4-[(2-methylpropan-2-yl)oxycarbonyl]phenoxy]undecanoylamino]pentanedioate Chemical class C([C@@H](C(=O)OC(C)(C)C)NC(=O)CCCCCCCCCCOC=1C=CC(=CC=1)C(=O)OC(C)(C)C)CC(=O)ON1C(=O)CCC1=O OZNXGCWWPFTBMA-MHZLTWQESA-N 0.000 description 1
• 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
• PGVRSPIEZYGOAD-UHFFFAOYSA-N 10-bromodecanoic acid Chemical compound OC(=O)CCCCCCCCCBr PGVRSPIEZYGOAD-UHFFFAOYSA-N 0.000 description 1
• OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
• YDTLALDCLABZKK-UHFFFAOYSA-N 11-[4-[(2-methylpropan-2-yl)oxycarbonyl]phenoxy]undecanoic acid Chemical compound CC(C)(C)OC(=O)C1=CC=C(OCCCCCCCCCCC(O)=O)C=C1 YDTLALDCLABZKK-UHFFFAOYSA-N 0.000 description 1
• JYNFXYXUSFOHLK-UHFFFAOYSA-N 11-[4-[(2-methylpropan-2-yl)oxycarbonyl]phenyl]sulfanylundecanoic acid Chemical compound CC(C)(C)OC(=O)C1=CC=C(SCCCCCCCCCCC(O)=O)C=C1 JYNFXYXUSFOHLK-UHFFFAOYSA-N 0.000 description 1
• 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
• BDHAQLJDYZFGNC-UHFFFAOYSA-N 15-[(2-methylpropan-2-yl)oxy]-15-oxopentadecanoic acid Chemical compound CC(C)(C)OC(=O)CCCCCCCCCCCCCC(O)=O BDHAQLJDYZFGNC-UHFFFAOYSA-N 0.000 description 1
• BBUPBICWUURTNP-UHFFFAOYSA-N 2,4-dimethyl-1-nitrobenzene Chemical group CC1=CC=C([N+]([O-])=O)C(C)=C1 BBUPBICWUURTNP-UHFFFAOYSA-N 0.000 description 1
• ZSONCFSFETVFEJ-UHFFFAOYSA-N 2-(10-bromodecanoylamino)-5-oxo-5-phenylmethoxypentanoic acid Chemical compound OC(=O)C(CCC(=O)OCc1ccccc1)NC(=O)CCCCCCCCCBr ZSONCFSFETVFEJ-UHFFFAOYSA-N 0.000 description 1
• FRYOUKNFWFXASU-UHFFFAOYSA-N 2-(methylamino)acetic acid Chemical group CNCC(O)=O.CNCC(O)=O FRYOUKNFWFXASU-UHFFFAOYSA-N 0.000 description 1
• DYNFCHNNOHNJFG-UHFFFAOYSA-N 2-formylbenzoic acid Chemical compound OC(=O)C1=CC=CC=C1C=O DYNFCHNNOHNJFG-UHFFFAOYSA-N 0.000 description 1
• QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
• IBGBGRVKPALMCQ-UHFFFAOYSA-N 3,4-dihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1O IBGBGRVKPALMCQ-UHFFFAOYSA-N 0.000 description 1
• VPSARXNVXCRDIV-UHFFFAOYSA-N 3-(4-boronophenyl)propanoic acid Chemical compound OB(O)C1=CC=C(CCC(O)=O)C=C1 VPSARXNVXCRDIV-UHFFFAOYSA-N 0.000 description 1
• VSSFPEXVAQWJQM-UHFFFAOYSA-N 3-(tert-butylamino)propanoic acid;hydrochloride Chemical compound Cl.CC(C)(C)NCCC(O)=O VSSFPEXVAQWJQM-UHFFFAOYSA-N 0.000 description 1
• UHDNUPHSDMOGCR-UHFFFAOYSA-N 3-Formylbenzoic acid Chemical compound OC(=O)C1=CC=CC(C=O)=C1 UHDNUPHSDMOGCR-UHFFFAOYSA-N 0.000 description 1
• FZYNXXVWXFCRGN-UHFFFAOYSA-N 3-[(2-methylpropan-2-yl)oxycarbonyl]-5-nitrobenzoic acid Chemical compound CC(C)(C)OC(=O)C1=CC(C(O)=O)=CC([N+]([O-])=O)=C1 FZYNXXVWXFCRGN-UHFFFAOYSA-N 0.000 description 1
• VOUAQYXWVJDEQY-QENPJCQMSA-N 33017-11-7 Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 VOUAQYXWVJDEQY-QENPJCQMSA-N 0.000 description 1
• PJDOQICZMZWRRM-UHFFFAOYSA-N 4-(10-methoxy-10-oxodecyl)sulfanylbenzoic acid;4-sulfanylbenzoic acid Chemical compound OC(=O)C1=CC=C(S)C=C1.COC(=O)CCCCCCCCCSC1=CC=C(C(O)=O)C=C1 PJDOQICZMZWRRM-UHFFFAOYSA-N 0.000 description 1
• KSVAZYVPPVHTEM-UHFFFAOYSA-N 4-(11-methoxy-11-oxoundecyl)sulfanylbenzoic acid Chemical compound COC(=O)CCCCCCCCCCSC1=CC=C(C(O)=O)C=C1 KSVAZYVPPVHTEM-UHFFFAOYSA-N 0.000 description 1
• PCOCFIOYWNCGBM-UHFFFAOYSA-N 4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoic acid Chemical compound CC(C)(C)OC(=O)CCC(O)=O PCOCFIOYWNCGBM-UHFFFAOYSA-N 0.000 description 1
• SWLAMJPTOQZTAE-UHFFFAOYSA-N 4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]benzoic acid Chemical class COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(C(O)=O)C=C1 SWLAMJPTOQZTAE-UHFFFAOYSA-N 0.000 description 1
• 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
• RDLBPRVBFVDDNJ-HKBQPEDESA-N 5-O-benzyl 1-O-tert-butyl (2S)-2-[10-[4-[(2-methylpropan-2-yl)oxycarbonyl]phenyl]sulfanyldecanoylamino]pentanedioate Chemical compound C([C@@H](C(=O)OC(C)(C)C)NC(=O)CCCCCCCCCSC=1C=CC(=CC=1)C(=O)OC(C)(C)C)CC(=O)OCC1=CC=CC=C1 RDLBPRVBFVDDNJ-HKBQPEDESA-N 0.000 description 1
• STHZIYZUBNXZFF-UHFFFAOYSA-N 5-[(2-methylpropan-2-yl)oxy]-2-[[2-[4-[2-[4-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]phenyl]ethyl]phenyl]acetyl]amino]-5-oxopentanoic acid Chemical compound CC(C)(C)OC(=O)CCC(NC(=O)Cc1ccc(CCc2ccc(CC(=O)OC(C)(C)C)cc2)cc1)C(O)=O STHZIYZUBNXZFF-UHFFFAOYSA-N 0.000 description 1
• XIXJRJUHVLMXBF-UHFFFAOYSA-N 5-[[[3-[(2-methylpropan-2-yl)oxy]-3-oxopropyl]amino]methyl]furan-2-carboxylic acid Chemical compound CC(C)(C)OC(=O)CCNCC1=CC=C(C(O)=O)O1 XIXJRJUHVLMXBF-UHFFFAOYSA-N 0.000 description 1
• SHNRXUWGUKDPMA-UHFFFAOYSA-N 5-formyl-2-furoic acid Chemical compound OC(=O)C1=CC=C(C=O)O1 SHNRXUWGUKDPMA-UHFFFAOYSA-N 0.000 description 1
• NBDAHKQJXVLAID-UHFFFAOYSA-N 5-nitroisophthalic acid Chemical compound OC(=O)C1=CC(C(O)=O)=CC([N+]([O-])=O)=C1 NBDAHKQJXVLAID-UHFFFAOYSA-N 0.000 description 1
• UPCPGYBSNWOJAI-YTTGMZPUSA-N 5-o-benzyl 1-o-tert-butyl (2s)-2-[11-[4-[(2-methylpropan-2-yl)oxycarbonyl]phenyl]sulfanylundecanoylamino]pentanedioate Chemical compound C([C@@H](C(=O)OC(C)(C)C)NC(=O)CCCCCCCCCCSC=1C=CC(=CC=1)C(=O)OC(C)(C)C)CC(=O)OCC1=CC=CC=C1 UPCPGYBSNWOJAI-YTTGMZPUSA-N 0.000 description 1
• FKEJKDMXMMOAQA-UHFFFAOYSA-N 5-o-benzyl 1-o-tert-butyl 2-(10-bromodecanoylamino)pentanedioate Chemical compound BrCCCCCCCCCC(=O)NC(C(=O)OC(C)(C)C)CCC(=O)OCC1=CC=CC=C1 FKEJKDMXMMOAQA-UHFFFAOYSA-N 0.000 description 1
• ASNYQFJYCPYLNH-UHFFFAOYSA-N 5-o-tert-butyl 1-o-(2,5-dioxopyrrolidin-1-yl) 2-[[2-[4-[2-[4-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]phenyl]ethyl]phenyl]acetyl]amino]pentanedioate Chemical compound O=C1CCC(=O)N1OC(=O)C(CCC(=O)OC(C)(C)C)NC(=O)CC(C=C1)=CC=C1CCC1=CC=C(CC(=O)OC(C)(C)C)C=C1 ASNYQFJYCPYLNH-UHFFFAOYSA-N 0.000 description 1
• SLXTWXQUEZSSTJ-UHFFFAOYSA-N 6-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl]pyridine-3-carboxylic acid Chemical compound CC1=CC(C(CCC2(C)C)(C)C)=C2C=C1C1(C=2N=CC(=CC=2)C(O)=O)CC1 SLXTWXQUEZSSTJ-UHFFFAOYSA-N 0.000 description 1
• FJVAQLJNTSUQPY-CIUDSAMLSA-N Ala-Ala-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN FJVAQLJNTSUQPY-CIUDSAMLSA-N 0.000 description 1
• 229940077274 Alpha glucosidase inhibitor Drugs 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• 101100277613 Aspergillus desertorum desB gene Proteins 0.000 description 1
• 210000002237 B-cell of pancreatic islet Anatomy 0.000 description 1
• 241000894006 Bacteria Species 0.000 description 1
• JXYACYYPACQCDM-UHFFFAOYSA-N Benzyl glycinate Chemical compound NCC(=O)OCC1=CC=CC=C1 JXYACYYPACQCDM-UHFFFAOYSA-N 0.000 description 1
• 229940123208 Biguanide Drugs 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 description 1
• QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 1
• 108010075254 C-Peptide Proteins 0.000 description 1
• 0 CC(C)(C)*C(C(CCC(ON(C(CC1)=O)C1=O)=O)NC(CCCCCCCCCOc(cc1)ccc1C(OC(C)(C)C)=O)=O)=O Chemical compound CC(C)(C)*C(C(CCC(ON(C(CC1)=O)C1=O)=O)NC(CCCCCCCCCOc(cc1)ccc1C(OC(C)(C)C)=O)=O)=O 0.000 description 1
• CAFNWYACMYBSOH-DEOSSOPVSA-N CC(C)(C)OC(=O)C1=CC=C(C=C1)SCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)OC(C)(C)C Chemical compound CC(C)(C)OC(=O)C1=CC=C(C=C1)SCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)OC(C)(C)C CAFNWYACMYBSOH-DEOSSOPVSA-N 0.000 description 1
• UZVKNTRHIVCHBP-VWLOTQADSA-N CC(C)(C)OC(=O)CC[C@H](NC(=O)CCCCCCCCCCSc1ccc(cc1)C(=O)OC(C)(C)C)C(O)=O Chemical compound CC(C)(C)OC(=O)CC[C@H](NC(=O)CCCCCCCCCCSc1ccc(cc1)C(=O)OC(C)(C)C)C(O)=O UZVKNTRHIVCHBP-VWLOTQADSA-N 0.000 description 1
• BQHSZHJHLAOVEA-VWLOTQADSA-N CC(C)(C)OC(=O)C[C@@H](C(=O)ON1C(=O)CCC1=O)NC(=O)CCCCCCCCCOC2=CC=C(C=C2)C(=O)OC(C)(C)C Chemical compound CC(C)(C)OC(=O)C[C@@H](C(=O)ON1C(=O)CCC1=O)NC(=O)CCCCCCCCCOC2=CC=C(C=C2)C(=O)OC(C)(C)C BQHSZHJHLAOVEA-VWLOTQADSA-N 0.000 description 1
• BQOSZNATNIHRSN-UHFFFAOYSA-N CC(C)(C)OC(CCN(Cc(cc1)ccc1C(ON(C(CC1)=O)C1=O)=O)C(CCCCCCCCCCCCCCC(OC(C)(C)C(C)=C)=O)=O)=O Chemical compound CC(C)(C)OC(CCN(Cc(cc1)ccc1C(ON(C(CC1)=O)C1=O)=O)C(CCCCCCCCCCCCCCC(OC(C)(C)C(C)=C)=O)=O)=O BQOSZNATNIHRSN-UHFFFAOYSA-N 0.000 description 1
• HQQITRIRGIYLPO-UHFFFAOYSA-N CC(C)(C)OC(CN(C(CCCCCCCCCCCCCCC([O]12=CC1C2(C)C)=O)=O)c(cc1)ccc1C(ON(C(CC1)=O)C1=O)=O)=O Chemical compound CC(C)(C)OC(CN(C(CCCCCCCCCCCCCCC([O]12=CC1C2(C)C)=O)=O)c(cc1)ccc1C(ON(C(CC1)=O)C1=O)=O)=O HQQITRIRGIYLPO-UHFFFAOYSA-N 0.000 description 1
• ISEHUWXFTVMMAK-UHFFFAOYSA-N CCC(C)(C)O/C(/CCNCc1cc(C(O)=O)ccc1)=[O]\C Chemical compound CCC(C)(C)O/C(/CCNCc1cc(C(O)=O)ccc1)=[O]\C ISEHUWXFTVMMAK-UHFFFAOYSA-N 0.000 description 1
• BIPWIGAWJIRIIU-UHFFFAOYSA-N CCC(C)(C)[O](C)C(c1cc(C(ON(C(CC2)=O)C2=O)=O)ccc1NC(CCCCCCCCCCCCCCC(OC(C)(C)C)=O)=O)=O Chemical compound CCC(C)(C)[O](C)C(c1cc(C(ON(C(CC2)=O)C2=O)=O)ccc1NC(CCCCCCCCCCCCCCC(OC(C)(C)C)=O)=O)=O BIPWIGAWJIRIIU-UHFFFAOYSA-N 0.000 description 1
• 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
• 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
• 108091006146 Channels Proteins 0.000 description 1
• GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
• 206010053567 Coagulopathies Diseases 0.000 description 1
• 108020004705 Codon Proteins 0.000 description 1
• 241000699802 Cricetulus griseus Species 0.000 description 1
• 229920000858 Cyclodextrin Polymers 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
• HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 1
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
• WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
• 229920002307 Dextran Polymers 0.000 description 1
• 229920001353 Dextrin Polymers 0.000 description 1
• 239000004375 Dextrin Substances 0.000 description 1
• FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
• 238000002965 ELISA Methods 0.000 description 1
• 102000004190 Enzymes Human genes 0.000 description 1
• 108090000790 Enzymes Proteins 0.000 description 1
• YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
• 241000588724 Escherichia coli Species 0.000 description 1
• 229930091371 Fructose Natural products 0.000 description 1
• 239000005715 Fructose Substances 0.000 description 1
• RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
• 241000233866 Fungi Species 0.000 description 1
• 102000051325 Glucagon Human genes 0.000 description 1
• 108060003199 Glucagon Proteins 0.000 description 1
• 229920001503 Glucan Polymers 0.000 description 1
• 239000007995 HEPES buffer Substances 0.000 description 1
• SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
• 101000610640 Homo sapiens U4/U6 small nuclear ribonucleoprotein Prp3 Proteins 0.000 description 1
• 229920001612 Hydroxyethyl starch Polymers 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 206010061218 Inflammation Diseases 0.000 description 1
• 102000003746 Insulin Receptor Human genes 0.000 description 1
• 108010001127 Insulin Receptor Proteins 0.000 description 1
• 229940122355 Insulin sensitizer Drugs 0.000 description 1
• 102000005237 Isophane Insulin Human genes 0.000 description 1
• 108010081368 Isophane Insulin Proteins 0.000 description 1
• LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
• OYIFNHCXNCRBQI-BYPYZUCNSA-N L-2-aminoadipic acid Chemical group OC(=O)[C@@H](N)CCCC(O)=O OYIFNHCXNCRBQI-BYPYZUCNSA-N 0.000 description 1
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
• 239000005639 Lauric acid Substances 0.000 description 1
• GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
• 229920001410 Microfiber Polymers 0.000 description 1
• FSVCELGFZIQNCK-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)glycine Chemical compound OCCN(CCO)CC(O)=O FSVCELGFZIQNCK-UHFFFAOYSA-N 0.000 description 1
• NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
• 239000007832 Na2SO4 Substances 0.000 description 1
• 229930193140 Neomycin Natural products 0.000 description 1
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
• VNQABZCSYCTZMS-UHFFFAOYSA-N Orthoform Chemical compound COC(=O)C1=CC=C(O)C(N)=C1 VNQABZCSYCTZMS-UHFFFAOYSA-N 0.000 description 1
• 235000021314 Palmitic acid Nutrition 0.000 description 1
• 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
• 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
• 206010035226 Plasma cell myeloma Diseases 0.000 description 1
• 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 229920001213 Polysorbate 20 Polymers 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• 102000004257 Potassium Channel Human genes 0.000 description 1
• 229940127315 Potassium Channel Openers Drugs 0.000 description 1
• OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
• 108010007568 Protamines Proteins 0.000 description 1
• 102000007327 Protamines Human genes 0.000 description 1
• 239000004373 Pullulan Substances 0.000 description 1
• 229920001218 Pullulan Polymers 0.000 description 1
• 108020004511 Recombinant DNA Proteins 0.000 description 1
• 101001110823 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L6-A Proteins 0.000 description 1
• 101000712176 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L6-B Proteins 0.000 description 1
• PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
• 239000004288 Sodium dehydroacetate Substances 0.000 description 1
• 229920002472 Starch Polymers 0.000 description 1
• 235000021355 Stearic acid Nutrition 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• 229940100389 Sulfonylurea Drugs 0.000 description 1
• UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 description 1
• FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
• 239000004098 Tetracycline Substances 0.000 description 1
• 229940123464 Thiazolidinedione Drugs 0.000 description 1
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
• 239000004473 Threonine Substances 0.000 description 1
• HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
• 239000007997 Tricine buffer Substances 0.000 description 1
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
• 102100040374 U4/U6 small nuclear ribonucleoprotein Prp3 Human genes 0.000 description 1
• TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
• 238000010521 absorption reaction Methods 0.000 description 1
• CSCPPACGZOOCGX-WFGJKAKNSA-N acetone d6 Chemical compound [2H]C([2H])([2H])C(=O)C([2H])([2H])[2H] CSCPPACGZOOCGX-WFGJKAKNSA-N 0.000 description 1
• PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 238000001042 affinity chromatography Methods 0.000 description 1
• 238000013019 agitation Methods 0.000 description 1
• 239000003888 alpha glucosidase inhibitor Substances 0.000 description 1
• HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
• BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
• 150000001408 amides Chemical class 0.000 description 1
• 229960003375 aminomethylbenzoic acid Drugs 0.000 description 1
• 229910021529 ammonia Inorganic materials 0.000 description 1
• 229960000723 ampicillin Drugs 0.000 description 1
• AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
• 150000008064 anhydrides Chemical class 0.000 description 1
• 239000005557 antagonist Substances 0.000 description 1
• 125000004653 anthracenylene group Chemical group 0.000 description 1
• 239000000883 anti-obesity agent Substances 0.000 description 1
• 239000002220 antihypertensive agent Substances 0.000 description 1
• 229940030600 antihypertensive agent Drugs 0.000 description 1
• 229940125710 antiobesity agent Drugs 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• 239000007900 aqueous suspension Substances 0.000 description 1
• PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
• 239000012300 argon atmosphere Substances 0.000 description 1
• UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
• 229960001950 benzethonium chloride Drugs 0.000 description 1
• 125000004603 benzisoxazolyl group Chemical group O1N=C(C2=C1C=CC=C2)* 0.000 description 1
• 229960004365 benzoic acid Drugs 0.000 description 1
• 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
• 235000019445 benzyl alcohol Nutrition 0.000 description 1
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
• SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
• 229940000635 beta-alanine Drugs 0.000 description 1
• GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
• 239000007998 bicine buffer Substances 0.000 description 1
• 150000004283 biguanides Chemical class 0.000 description 1
• 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
• 239000008280 blood Substances 0.000 description 1
• 210000004369 blood Anatomy 0.000 description 1
• 239000010836 blood and blood product Substances 0.000 description 1
• 230000017531 blood circulation Effects 0.000 description 1
• 229940125691 blood product Drugs 0.000 description 1
• 229960003168 bronopol Drugs 0.000 description 1
• KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
• 239000006227 byproduct Substances 0.000 description 1
• 210000004899 c-terminal region Anatomy 0.000 description 1
• 238000004364 calculation method Methods 0.000 description 1
• 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
• 125000005566 carbazolylene group Chemical group 0.000 description 1
• 239000001768 carboxy methyl cellulose Substances 0.000 description 1
• 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
• 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
• 150000001768 cations Chemical class 0.000 description 1
• 239000007795 chemical reaction product Substances 0.000 description 1
• 229960005091 chloramphenicol Drugs 0.000 description 1
• WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
• 229960003260 chlorhexidine Drugs 0.000 description 1
• 150000001805 chlorine compounds Chemical class 0.000 description 1
• 229960004926 chlorobutanol Drugs 0.000 description 1
• 229960002242 chlorocresol Drugs 0.000 description 1
• 230000002759 chromosomal effect Effects 0.000 description 1
• 210000000349 chromosome Anatomy 0.000 description 1
• 238000003776 cleavage reaction Methods 0.000 description 1
• 230000035602 clotting Effects 0.000 description 1
• 238000012258 culturing Methods 0.000 description 1
• 230000007547 defect Effects 0.000 description 1
• 238000012217 deletion Methods 0.000 description 1
• 230000037430 deletion Effects 0.000 description 1
• 238000001212 derivatisation Methods 0.000 description 1
• 235000019425 dextrin Nutrition 0.000 description 1
• KJOZJSGOIJQCGA-UHFFFAOYSA-N dichloromethane;2,2,2-trifluoroacetic acid Chemical compound ClCCl.OC(=O)C(F)(F)F KJOZJSGOIJQCGA-UHFFFAOYSA-N 0.000 description 1
• ORPJQSFBLBHKPN-UHFFFAOYSA-N dichloromethane;methylsulfinylmethane Chemical compound ClCCl.CS(C)=O ORPJQSFBLBHKPN-UHFFFAOYSA-N 0.000 description 1
• 235000005911 diet Nutrition 0.000 description 1
• 230000037213 diet Effects 0.000 description 1
• KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 1
• DOSDTCPDBPRFHQ-UHFFFAOYSA-N dimethyl 5-hydroxybenzene-1,3-dicarboxylate Chemical compound COC(=O)C1=CC(O)=CC(C(=O)OC)=C1 DOSDTCPDBPRFHQ-UHFFFAOYSA-N 0.000 description 1
• BEPAFCGSDWSTEL-UHFFFAOYSA-N dimethyl malonate Chemical compound COC(=O)CC(=O)OC BEPAFCGSDWSTEL-UHFFFAOYSA-N 0.000 description 1
• 238000007599 discharging Methods 0.000 description 1
• BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
• 238000004821 distillation Methods 0.000 description 1
• 238000009826 distribution Methods 0.000 description 1
• BXAYDXUVVFXKSE-UHFFFAOYSA-N ditert-butyl 4-nitrobenzene-1,3-dicarboxylate Chemical compound CC(C)(C)OC(=O)C1=CC=C([N+]([O-])=O)C(C(=O)OC(C)(C)C)=C1 BXAYDXUVVFXKSE-UHFFFAOYSA-N 0.000 description 1
• 238000001035 drying Methods 0.000 description 1
• 229920001971 elastomer Polymers 0.000 description 1
• 238000005516 engineering process Methods 0.000 description 1
• 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
• 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
• 229940043351 ethyl-p-hydroxybenzoate Drugs 0.000 description 1
• NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
• 210000003527 eukaryotic cell Anatomy 0.000 description 1
• 238000001704 evaporation Methods 0.000 description 1
• 239000013604 expression vector Substances 0.000 description 1
• 239000000284 extract Substances 0.000 description 1
• 230000002349 favourable effect Effects 0.000 description 1
• 125000005567 fluorenylene group Chemical group 0.000 description 1
• 239000006260 foam Substances 0.000 description 1
• 230000037406 food intake Effects 0.000 description 1
• 235000012631 food intake Nutrition 0.000 description 1
• 239000001530 fumaric acid Substances 0.000 description 1
• 235000011087 fumaric acid Nutrition 0.000 description 1
• 238000001641 gel filtration chromatography Methods 0.000 description 1
• 239000012362 glacial acetic acid Substances 0.000 description 1
• MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
• 229960004666 glucagon Drugs 0.000 description 1
• 230000004190 glucose uptake Effects 0.000 description 1
• 150000004676 glycans Chemical class 0.000 description 1
• 230000004116 glycogenolysis Effects 0.000 description 1
• 239000001963 growth medium Substances 0.000 description 1
• 125000001072 heteroaryl group Chemical group 0.000 description 1
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
• 238000009396 hybridization Methods 0.000 description 1
• 230000007062 hydrolysis Effects 0.000 description 1
• 238000006460 hydrolysis reaction Methods 0.000 description 1
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
• 229940050526 hydroxyethylstarch Drugs 0.000 description 1
• 229940126904 hypoglycaemic agent Drugs 0.000 description 1
• 230000002218 hypoglycaemic effect Effects 0.000 description 1
• 150000002462 imidazolines Chemical class 0.000 description 1
• ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
• 229940113174 imidurea Drugs 0.000 description 1
• 230000016784 immunoglobulin production Effects 0.000 description 1
• 238000001727 in vivo Methods 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• 238000001802 infusion Methods 0.000 description 1
• 239000007972 injectable composition Substances 0.000 description 1
• 229960000367 inositol Drugs 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 239000013067 intermediate product Substances 0.000 description 1
• 238000010255 intramuscular injection Methods 0.000 description 1
• 238000010253 intravenous injection Methods 0.000 description 1
• YAQXGBBDJYBXKL-UHFFFAOYSA-N iron(2+);1,10-phenanthroline;dicyanide Chemical compound [Fe+2].N#[C-].N#[C-].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 YAQXGBBDJYBXKL-UHFFFAOYSA-N 0.000 description 1
• 238000010829 isocratic elution Methods 0.000 description 1
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
• 229960000310 isoleucine Drugs 0.000 description 1
• FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
• 229960000318 kanamycin Drugs 0.000 description 1
• 229930027917 kanamycin Natural products 0.000 description 1
• SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
• 229930182823 kanamycin A Natural products 0.000 description 1
• 239000008101 lactose Substances 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• 238000012417 linear regression Methods 0.000 description 1
• 230000037356 lipid metabolism Effects 0.000 description 1
• 239000012669 liquid formulation Substances 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
• 239000011976 maleic acid Substances 0.000 description 1
• 239000001630 malic acid Substances 0.000 description 1
• 235000011090 malic acid Nutrition 0.000 description 1
• 239000003550 marker Substances 0.000 description 1
• 235000012054 meals Nutrition 0.000 description 1
• 229950004994 meglitinide Drugs 0.000 description 1
• 229960000485 methotrexate Drugs 0.000 description 1
• LZXXNPOYQCLXRS-UHFFFAOYSA-N methyl 4-aminobenzoate Chemical compound COC(=O)C1=CC=C(N)C=C1 LZXXNPOYQCLXRS-UHFFFAOYSA-N 0.000 description 1
• 244000005700 microbiome Species 0.000 description 1
• 239000003658 microfiber Substances 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• 239000002808 molecular sieve Substances 0.000 description 1
• 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
• 235000019799 monosodium phosphate Nutrition 0.000 description 1
• 239000012452 mother liquor Substances 0.000 description 1
• 201000000050 myeloid neoplasm Diseases 0.000 description 1
• 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 125000004957 naphthylene group Chemical group 0.000 description 1
• OELFLUMRDSZNSF-BRWVUGGUSA-N nateglinide Chemical compound C1C[C@@H](C(C)C)CC[C@@H]1C(=O)N[C@@H](C(O)=O)CC1=CC=CC=C1 OELFLUMRDSZNSF-BRWVUGGUSA-N 0.000 description 1
• 229960000698 nateglinide Drugs 0.000 description 1
• 229960004927 neomycin Drugs 0.000 description 1
• 125000006611 nonyloxy group Chemical group 0.000 description 1
• 238000012587 nuclear overhauser effect experiment Methods 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
• OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
• 239000002751 oligonucleotide probe Substances 0.000 description 1
• YDCVQGAUCOROHB-UHFFFAOYSA-N oxadiazolidine-4,5-dione Chemical class O=C1NNOC1=O YDCVQGAUCOROHB-UHFFFAOYSA-N 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 238000007254 oxidation reaction Methods 0.000 description 1
• 230000037361 pathway Effects 0.000 description 1
• 239000008188 pellet Substances 0.000 description 1
• JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 description 1
• 239000000546 pharmaceutical excipient Substances 0.000 description 1
• 239000003186 pharmaceutical solution Substances 0.000 description 1
• 125000005560 phenanthrenylene group Chemical group 0.000 description 1
• 229960005323 phenoxyethanol Drugs 0.000 description 1
• WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
• 229960003424 phenylacetic acid Drugs 0.000 description 1
• 239000003279 phenylacetic acid Substances 0.000 description 1
• COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
• 239000008363 phosphate buffer Substances 0.000 description 1
• 230000037081 physical activity Effects 0.000 description 1
• 239000013612 plasmid Substances 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 238000003752 polymerase chain reaction Methods 0.000 description 1
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
• 229920001282 polysaccharide Polymers 0.000 description 1
• 239000005017 polysaccharide Substances 0.000 description 1
• 229920005990 polystyrene resin Polymers 0.000 description 1
• 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
• 230000018656 positive regulation of gluconeogenesis Effects 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• 229910000027 potassium carbonate Inorganic materials 0.000 description 1
• 108020001213 potassium channel Proteins 0.000 description 1
• 239000003450 potassium channel blocker Substances 0.000 description 1
• 239000012286 potassium permanganate Substances 0.000 description 1
• 238000002360 preparation method Methods 0.000 description 1
• 235000019260 propionic acid Nutrition 0.000 description 1
• 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
• 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
• QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
• 229940048914 protamine Drugs 0.000 description 1
• 235000004252 protein component Nutrition 0.000 description 1
• 235000019423 pullulan Nutrition 0.000 description 1
• 238000001953 recrystallisation Methods 0.000 description 1
• 230000009467 reduction Effects 0.000 description 1
• 230000002829 reductive effect Effects 0.000 description 1
• HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
• 230000007017 scission Effects 0.000 description 1
• DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
• 239000000741 silica gel Substances 0.000 description 1
• 229910002027 silica gel Inorganic materials 0.000 description 1
• URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
• 229910000029 sodium carbonate Inorganic materials 0.000 description 1
• 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
• 229940079839 sodium dehydroacetate Drugs 0.000 description 1
• AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
• 239000004317 sodium nitrate Substances 0.000 description 1
• 235000010344 sodium nitrate Nutrition 0.000 description 1
• 239000012064 sodium phosphate buffer Substances 0.000 description 1
• 229910052938 sodium sulfate Inorganic materials 0.000 description 1
• 235000011152 sodium sulphate Nutrition 0.000 description 1
• DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
• 239000000600 sorbitol Substances 0.000 description 1
• 241000894007 species Species 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 210000004989 spleen cell Anatomy 0.000 description 1
• 239000007921 spray Substances 0.000 description 1
• 230000000087 stabilizing effect Effects 0.000 description 1
• 239000008107 starch Substances 0.000 description 1
• 235000019698 starch Nutrition 0.000 description 1
• 239000008117 stearic acid Substances 0.000 description 1
• 239000000021 stimulant Substances 0.000 description 1
• 239000012258 stirred mixture Substances 0.000 description 1
• 238000003860 storage Methods 0.000 description 1
• 238000010254 subcutaneous injection Methods 0.000 description 1
• 239000000126 substance Substances 0.000 description 1
• 125000000185 sucrose group Chemical group 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
• 230000009469 supplementation Effects 0.000 description 1
• 238000001356 surgical procedure Methods 0.000 description 1
• 239000011975 tartaric acid Substances 0.000 description 1
• 235000002906 tartaric acid Nutrition 0.000 description 1
• 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• HIUABDANPBVDKW-UHFFFAOYSA-N tert-butyl 18-[[3-[(2-methylpropan-2-yl)oxy]-3-oxopropyl]-(2-oxo-2-phenylmethoxyethyl)amino]-18-oxooctadecanoate Chemical compound CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCC(=O)N(CCC(=O)OC(C)(C)C)CC(=O)OCC1=CC=CC=C1 HIUABDANPBVDKW-UHFFFAOYSA-N 0.000 description 1
• SDTZMMHGVHGEJQ-UHFFFAOYSA-N tert-butyl 3-[(2-oxo-2-phenylmethoxyethyl)amino]propanoate Chemical compound CC(C)(C)OC(=O)CCNCC(=O)OCC1=CC=CC=C1 SDTZMMHGVHGEJQ-UHFFFAOYSA-N 0.000 description 1
• DOMTZTVJNZKUNX-UHFFFAOYSA-N tert-butyl 3-aminopropanoate;hydrochloride Chemical compound Cl.CC(C)(C)OC(=O)CCN DOMTZTVJNZKUNX-UHFFFAOYSA-N 0.000 description 1
• SLCOUYCVBNDVQT-UHFFFAOYSA-N tert-butyl 4-(10-methoxy-10-oxodecoxy)benzoate;10-[4-[(2-methylpropan-2-yl)oxycarbonyl]phenoxy]decanoic acid Chemical compound CC(C)(C)OC(=O)C1=CC=C(OCCCCCCCCCC(O)=O)C=C1.COC(=O)CCCCCCCCCOC1=CC=C(C(=O)OC(C)(C)C)C=C1 SLCOUYCVBNDVQT-UHFFFAOYSA-N 0.000 description 1
• MCWVCHWCPZADLA-UHFFFAOYSA-N tert-butyl 4-(10-methoxy-10-oxodecyl)sulfanylbenzoate Chemical compound COC(=O)CCCCCCCCCSC1=CC=C(C(=O)OC(C)(C)C)C=C1 MCWVCHWCPZADLA-UHFFFAOYSA-N 0.000 description 1
• CKXJHDOFIVIQDJ-UHFFFAOYSA-N tert-butyl 4-(10-methoxy-10-oxodecyl)sulfanylbenzoate;10-[4-[(2-methylpropan-2-yl)oxycarbonyl]phenyl]sulfanyldecanoic acid Chemical compound CC(C)(C)OC(=O)C1=CC=C(SCCCCCCCCCC(O)=O)C=C1.COC(=O)CCCCCCCCCSC1=CC=C(C(=O)OC(C)(C)C)C=C1 CKXJHDOFIVIQDJ-UHFFFAOYSA-N 0.000 description 1
• SGQWJBRQANKRDL-UHFFFAOYSA-N tert-butyl 4-(11-methoxy-11-oxoundecoxy)benzoate Chemical compound COC(=O)CCCCCCCCCCOC1=CC=C(C(=O)OC(C)(C)C)C=C1 SGQWJBRQANKRDL-UHFFFAOYSA-N 0.000 description 1
• UMGSKDRDEJEHCW-UHFFFAOYSA-N tert-butyl 4-(11-methoxy-11-oxoundecyl)sulfanylbenzoate Chemical compound COC(=O)CCCCCCCCCCSC1=CC=C(C(=O)OC(C)(C)C)C=C1 UMGSKDRDEJEHCW-UHFFFAOYSA-N 0.000 description 1
• KHNLCRFPQCKTFJ-UHFFFAOYSA-N tert-butyl 4-[10-(2,5-dioxopyrrolidin-1-yl)oxy-10-oxodecoxy]benzoate;10-[4-[(2-methylpropan-2-yl)oxycarbonyl]phenoxy]decanoic acid Chemical compound CC(C)(C)OC(=O)C1=CC=C(OCCCCCCCCCC(O)=O)C=C1.C1=CC(C(=O)OC(C)(C)C)=CC=C1OCCCCCCCCCC(=O)ON1C(=O)CCC1=O KHNLCRFPQCKTFJ-UHFFFAOYSA-N 0.000 description 1
• UMWGIXQJSJNNBD-UHFFFAOYSA-N tert-butyl 4-[11-(2,5-dioxopyrrolidin-1-yl)oxy-11-oxoundecoxy]benzoate Chemical compound C1=CC(C(=O)OC(C)(C)C)=CC=C1OCCCCCCCCCCC(=O)ON1C(=O)CCC1=O UMWGIXQJSJNNBD-UHFFFAOYSA-N 0.000 description 1
• FHIKQSWMLKCATP-UHFFFAOYSA-N tert-butyl 4-hydroxybenzoate;tert-butyl 4-(10-methoxy-10-oxodecoxy)benzoate Chemical compound CC(C)(C)OC(=O)C1=CC=C(O)C=C1.COC(=O)CCCCCCCCCOC1=CC=C(C(=O)OC(C)(C)C)C=C1 FHIKQSWMLKCATP-UHFFFAOYSA-N 0.000 description 1
• LYDRKKWPKKEMNZ-UHFFFAOYSA-N tert-butyl benzoate Chemical compound CC(C)(C)OC(=O)C1=CC=CC=C1 LYDRKKWPKKEMNZ-UHFFFAOYSA-N 0.000 description 1
• FQFILJKFZCVHNH-UHFFFAOYSA-N tert-butyl n-[3-[(5-bromo-2-chloropyrimidin-4-yl)amino]propyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCNC1=NC(Cl)=NC=C1Br FQFILJKFZCVHNH-UHFFFAOYSA-N 0.000 description 1
• ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
• 229960002180 tetracycline Drugs 0.000 description 1
• 229930101283 tetracycline Natural products 0.000 description 1
• 235000019364 tetracycline Nutrition 0.000 description 1
• 150000003522 tetracyclines Chemical class 0.000 description 1
• ZTUXEFFFLOVXQE-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCC(O)=O ZTUXEFFFLOVXQE-UHFFFAOYSA-N 0.000 description 1
• 230000001225 therapeutic effect Effects 0.000 description 1
• 150000001467 thiazolidinediones Chemical class 0.000 description 1
• 230000002103 transcriptional effect Effects 0.000 description 1
• 238000013519 translation Methods 0.000 description 1
• HHLJUSLZGFYWKW-UHFFFAOYSA-N triethanolamine hydrochloride Chemical compound Cl.OCCN(CCO)CCO HHLJUSLZGFYWKW-UHFFFAOYSA-N 0.000 description 1
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
• 239000011800 void material Substances 0.000 description 1
• 238000005406 washing Methods 0.000 description 1
• 238000001262 western blot Methods 0.000 description 1
• 239000000811 xylitol Substances 0.000 description 1
• 235000010447 xylitol Nutrition 0.000 description 1
• HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
• 229960002675 xylitol Drugs 0.000 description 1
• 150000003751 zinc Chemical class 0.000 description 1